Innate Pharma and Astrazeneca announce co-development and commercialisation collaboration for IPH2201
24 April 2015 | By Victoria White
Innate Pharma has signed a co-development and commercialisation agreement with AstraZeneca to accelerate and broaden the development of IPH2201...